May 23, 2018 / 11:17 AM / 7 months ago

BRIEF-Valeritas’ Says V-Go Insulin Delivery Device Demonstrates Positive Clinical Benefits In Type 2 Diabetes Patients

May 23 (Reuters) - Valeritas Holdings Inc:

* VALERITAS’ V-GO® WEARABLE INSULIN DELIVERY DEVICE DEMONSTRATES POSITIVE CLINICAL AND ECONOMIC BENEFITS IN PATIENTS WITH TYPE 2 DIABETES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below